Biocon board will approve financial results

17 Jul 2012 Evaluate
Biocon has informed that a meeting of the board of directors of the company will be held on July 25, 2012,  to approve and take on record the unaudited financial results of the company for the quarter ended on June 30, 2012 and the merger of Biocon Biopharmaceuticals Limited; a wholly owned subsidiary with the company.

The above information is a part of company's filings submitted to BSE.

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×